{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:09:07Z","timestamp":1782504547836,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["LI-1042\/3-1"],"award-info":[{"award-number":["LI-1042\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["BMBF 01EO1003"],"award-info":[{"award-number":["BMBF 01EO1003"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:sec>\n                <jats:title>Abstract<\/jats:title>\n                <jats:p>Preeclampsia is a common medical condition during pregnancy and a major cause of maternal and prenatal mortality. The present study was conducted to investigate the effects of maternal treatment with pentaerythritol tetranitrate (PETN) in Dahl salt-sensitive rats (DSSR), a model of superimposed preeclampsia. F0 parental DSSR were treated with PETN (50\u00a0mg\/kg) from the time point of mating to the end of lactation. Maternal PETN treatment improved fetal growth and had no effect on blood pressure in DSSR offspring fed with normal chow or high-salt diet. Upon high-fat diet (HFD) feeding, offspring from PETN-treated mother showed improved glucose tolerance despite similar weight gain. Unexpectedly, maternal PETN treatment significantly potentiated the HFD-induced blood pressure elevation in male DSSR offspring. Endothelium-derived hyperpolarization factor (EDHF)-mediated vasodilation was similar between NCD-fed and HFD-fed control offspring but was markedly reduced in HFD-fed PETN offspring. EDHF genes were downregulated in the vasculature of HFD-fed PETN offspring, which was associated with epigenetic changes in histone modifications. In conclusion, maternal PETN treatment in DSSR shows both beneficial and unfavorable effects. It improves fetal growth and ameliorates glucose tolerance in the offspring. Although maternal PETN treatment has no effect on blood pressure in offspring fed with normal chow or high-salt diet, the offspring is at higher risk to develop HFD-induced hypertension. PETN may potentiate the blood pressure response to HFD by epigenetic modifications of EDHF genes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key messages<\/jats:title>\n                <jats:p><jats:italic>The core findings of this article suggest that maternal PETN treatment of DSSR, a rat model of a spontaneous superimposed preeclampsia, leads to<\/jats:italic><\/jats:p>\n                <jats:p>\u2022 <jats:italic>Improvement of fetal growth;<\/jats:italic><\/jats:p>\n                <jats:p>\u2022 <jats:italic>No changes of maternal blood pressure or markers of preeclampsia;<\/jats:italic><\/jats:p>\n                <jats:p>\u2022 <jats:italic>Amelioration of HFD-induced glucose intolerance in adult offspring;<\/jats:italic><\/jats:p>\n                <jats:p>\u2022 <jats:italic>No changes in blood pressure development of the offspring on normal chow or high salt-diet;<\/jats:italic><\/jats:p>\n                <jats:p>\u2022 <jats:italic>Potentiation of blood pressure elevation of the offspring on HFD.<\/jats:italic><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00109-020-01949-0","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T06:04:48Z","timestamp":1596434688000},"page":"1287-1299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Fetal programming effects of pentaerythritol tetranitrate in a rat model of superimposed preeclampsia"],"prefix":"10.1007","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4113-6479","authenticated-orcid":false,"given":"Andy W. C.","family":"Man","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Reifenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Daiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"M\u00fcnzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huige","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"issue":"2","key":"1949_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/GCO.0b013e32835e0ef5","volume":"25","author":"JO Lo","year":"2013","unstructured":"Lo JO, Mission JF, Caughey AB (2013) Hypertensive disease of pregnancy and maternal mortality. Curr Opin Obstet Gyn 25(2):124\u2013132","journal-title":"Curr Opin Obstet Gyn"},{"issue":"2","key":"1949_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1161\/HYPERTENSIONAHA.118.11092","volume":"72","author":"FL Foo","year":"2018","unstructured":"Foo FL, Mahendru AA, Masini G, Fraser A, Cacciatore S, MacIntyre DA, McEniery CM, Wilkinson IB, Bennett PR, Lees CC (2018) Association between prepregnancy cardiovascular function and subsequent preeclampsia or fetal growth restriction. Hypertension 72(2):442\u2013450","journal-title":"Hypertension"},{"issue":"1","key":"1949_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.preghy.2012.11.001","volume":"3","author":"AL Tranquilli","year":"2013","unstructured":"Tranquilli AL, Brown MA, Zeeman GG, Dekker G, Sibai BM (2013) The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of hypertension in pregnancy (ISSHP). Pregnancy Hypertens 3(1):44\u201347","journal-title":"Pregnancy Hypertens"},{"issue":"7","key":"1949_CR4","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","volume":"125","author":"S Rana","year":"2012","unstructured":"Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, Lim KH, Wenger JB, Thadhani R, Karumanchi SA (2012) Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 125(7):911\u2013919","journal-title":"Circulation"},{"key":"1949_CR5","doi-asserted-by":"crossref","unstructured":"Mandruzzato G, Antsaklis A, Botet F, Chervenak FA, Figueras F, Grunebaum A, Puerto B, Skupski D, Stanojevic M, Wapm (2008) Intrauterine restriction (IUGR). J Perinat Med 36 (4):277\u2013281.","DOI":"10.1515\/JPM.2008.050"},{"issue":"6","key":"1949_CR6","first-page":"950","volume":"96","author":"RA \u00d8deg\u00e5rd","year":"2000","unstructured":"\u00d8deg\u00e5rd RA, Vatten LJ, Nilsen ST, Salvesen K\u00c5, Austgulen R (2000) Preeclampsia and fetal growth. Obstet Gynecol 96(6):950\u2013955","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1949_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1056\/NEJMra0708473","volume":"359","author":"PD Gluckman","year":"2008","unstructured":"Gluckman PD, Hanson MA, Cooper C, Thornburg KL (2008) Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 359(1):61\u201373","journal-title":"N Engl J Med"},{"issue":"2","key":"1949_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1053\/j.ackd.2008.01.001","volume":"15","author":"NB Ojeda","year":"2008","unstructured":"Ojeda NB, Grigore D, Alexander BT (2008) Intrauterine growth restriction: fetal programming of hypertension and kidney disease. Adv Chronic Kidney Dis 15(2):101\u2013106","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"1949_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13148-015-0052-x","volume":"7","author":"T Ching","year":"2015","unstructured":"Ching T, Ha J, Song MA, Tiirikainen M, Molnar J, Berry MJ, Towner D, Garmire LX (2015) Genome-scale hypomethylation in the cord blood DNAs associated with early onset preeclampsia. Clin Epigenetics 7(1):21","journal-title":"Clin Epigenetics"},{"issue":"9","key":"1949_CR10","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S1357-4310(95)90793-9","volume":"1","author":"DJ Barker","year":"1995","unstructured":"Barker DJ (1995) Intrauterine programming of adult disease. Mol Med Today 1(9):418\u2013423","journal-title":"Mol Med Today"},{"issue":"3","key":"1949_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","volume":"218","author":"S Roberge","year":"2018","unstructured":"Roberge S, Bujold E, Nicolaides KH (2018) Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol 218(3):287\u2013293.e281","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1949_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/oxfordjournals.epirev.a036049","volume":"12","author":"I Hertz-Picciotto","year":"1990","unstructured":"Hertz-Picciotto I, Hopenhayn-Rich C, Golub M, Hooper K (1990) The risks and benefits of taking aspirin during pregnancy. Epidemiol Rev 12(1):108\u2013148","journal-title":"Epidemiol Rev"},{"issue":"2","key":"1949_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1046\/j.1469-0705.1999.14020101.x","volume":"14","author":"G Luzi","year":"1999","unstructured":"Luzi G, Caserta G, Iammarino G, Clerici G, Di Renzo GC (1999) Nitric oxide donors in pregnancy: fetomaternal hemodynamic effects induced in mild pre-eclampsia and threatened preterm labor. Ultrasound Obst Gyn 14(2):101\u2013109","journal-title":"Ultrasound Obst Gyn"},{"issue":"4","key":"1949_CR14","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/HYPERTENSIONAHA.109.149542","volume":"55","author":"S Schuhmacher","year":"2010","unstructured":"Schuhmacher S, Wenzel P, Schulz E, Oelze M, Mang C, Kamuf J, Gori T, Jansen T, Knorr M, Karbach S, Hortmann M, Mathner F, Bhatnagar A, Forstermann U, Li H, Munzel T, Daiber A (2010) Pentaerythritol Tetranitrate improves angiotensin II-induced vascular dysfunction via induction of Heme Oxygenase-1. Hypertension 55(4):897\u2013U153","journal-title":"Hypertension"},{"issue":"10","key":"1949_CR15","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.2337\/db10-1395","volume":"60","author":"S Schuhmacher","year":"2011","unstructured":"Schuhmacher S, Oelze M, Bollmann F, Kleinert H, Otto C, Heeren T, Steven S, Hausding M, Knorr M, Pautz A (2011) Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy. Diabetes 60(10):2608\u20132616","journal-title":"Diabetes"},{"issue":"1","key":"1949_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/bdrb.20184","volume":"86","author":"MJ Quinn Jr","year":"2009","unstructured":"Quinn MJ Jr, Crouse LC, McFarland CA, LaFiandra EM, Johnson MS (2009) Reproductive and developmental effects and physical and chemical properties of pentaerythritol tetranitrate (PETN) in the rat. Birth Defects Res B Dev Reprod Toxicol 86(1):65\u201371","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"issue":"4","key":"1949_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1515\/jpm-2013-0212","volume":"42","author":"E Schleussner","year":"2014","unstructured":"Schleussner E, Lehmann T, Kahler C, Schneider U, Schlembach D, Groten T (2014) Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: a prospective, randomized, double-blinded trial. J Perinat Med 42(4):507\u2013514","journal-title":"J Perinat Med"},{"issue":"9","key":"1949_CR18","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1515\/jpm-2017-0238","volume":"46","author":"S Bowkalow","year":"2018","unstructured":"Bowkalow S, Schleussner E, Kahler C, Schneider U, Lehmann T, Groten T (2018) Pentaerythrityltetranitrate (PETN) improves utero- and feto-placental Doppler parameters in pregnancies with impaired utero-placental perfusion in mid-gestation - a secondary analysis of the PETN-pilot trial. J Perinat Med 46(9):1004\u20131009","journal-title":"J Perinat Med"},{"issue":"1","key":"1949_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1161\/HYPERTENSIONAHA.114.04416","volume":"65","author":"Z Wu","year":"2015","unstructured":"Wu Z, Siuda D, Xia N, Reifenberg G, Daiber A, Munzel T, Forstermann U, Li H (2015) Maternal treatment of spontaneously hypertensive rats with pentaerythritol tetranitrate reduces blood pressure in female offspring. Hypertension 65(1):232\u2013237","journal-title":"Hypertension"},{"key":"1949_CR20","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3389\/fphar.2020.00454","volume":"11","author":"AWC Man","year":"2020","unstructured":"Man AWC, Chen M, Wu Z, Reifenberg G, Daiber A, Munzel T, Xia N, Li H (2020) Renal effects of Fetal reprogramming with Pentaerythritol Tetranitrate in spontaneously hypertensive rats. Front Pharmacol 11:454","journal-title":"Front Pharmacol"},{"issue":"6","key":"1949_CR21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1161\/01.HYP.4.6.753","volume":"4","author":"JP Rapp","year":"1982","unstructured":"Rapp JP (1982) Dahl salt-susceptible and salt-resistant rats. A Review Hypertension 4(6):753\u2013763","journal-title":"A Review Hypertension"},{"issue":"1","key":"1949_CR22","first-page":"R62","volume":"309","author":"EE Gillis","year":"2015","unstructured":"Gillis EE, Williams JM, Garrett MR, Mooney JN, Sasser JM (2015) The dahl salt-sensitive rat is a spontaneous model of superimposed preeclampsia. Am J Physiol-Reg I 309(1):R62\u2013R70","journal-title":"Am J Physiol-Reg I"},{"issue":"5","key":"1949_CR23","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1161\/HYPERTENSIONAHA.118.12454","volume":"73","author":"F Terstappen","year":"2019","unstructured":"Terstappen F, Spradley FT, Bakrania BA, Clarke SM, Joles JA, Paauw ND, Garrett MR, Lely AT, Sasser JM (2019) Prenatal sildenafil therapy improves cardiovascular function in Fetal growth restricted offspring of dahl salt-sensitive rats. Hypertension 73(5):1120\u20131127","journal-title":"Hypertension"},{"issue":"6","key":"1949_CR24","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","volume":"116","author":"JE Hall","year":"2015","unstructured":"Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME (2015) Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res 116(6):991\u20131006","journal-title":"Circ Res"},{"issue":"20","key":"1949_CR25","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1111\/bph.13703","volume":"174","author":"N Xia","year":"2017","unstructured":"Xia N, Weisenburger S, Koch E, Burkart M, Reifenberg G, F\u00f6rstermann U, Li H (2017) Restoration of perivascular adipose tissue function in dietinduced obese mice without changing bodyweight. Br J Pharmacol 174(20):3443\u20133453","journal-title":"Br J Pharmacol"},{"issue":"5","key":"1949_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/10641960902825487","volume":"31","author":"A Nagae","year":"2009","unstructured":"Nagae A, Fujita M, Kawarazaki H, Matsui H, Ando K, Fujita T (2009) Effect of high fat loading in dahl salt-sensitive rats. Clin Exp Hypertens 31(5):451\u2013461","journal-title":"Clin Exp Hypertens"},{"key":"1949_CR27","doi-asserted-by":"crossref","unstructured":"Spradley FT, De Miguel C, Hobbs J, Pollock DM, Pollock JS (2013) Mycophenolate mofetil prevents high-fat diet\u2013induced hypertension and renal glomerular injury in dahl SS rats. Physiol Rep 1(6)","DOI":"10.1002\/phy2.137"},{"issue":"6","key":"1949_CR28","first-page":"H1713","volume":"315","author":"LE Taylor","year":"2018","unstructured":"Taylor LE, Gillis EE, Musall JB, Baban B, Sullivan JC (2018) High-fat diet-induced hypertension is associated with a proinflammatory T cell profile in male and female dahl salt-sensitive rats. Am J Phys Heart Circ Phys 315(6):H1713\u2013H1723","journal-title":"Am J Phys Heart Circ Phys"},{"key":"1949_CR29","doi-asserted-by":"crossref","unstructured":"Taylor LE, Gillis EE, Musall JB, Baban B, Sullivan JC (2018) High fat diet induced hypertension is associated with a pro-inflammatory T cell profile in male and female dahl salt sensitive rats. American Journal of Physiology-Heart and Circulatory Physiology","DOI":"10.1152\/ajpheart.00389.2018"},{"key":"1949_CR30","doi-asserted-by":"crossref","unstructured":"Spradley FT, Pollock DM, Pollock JS (2010) Dahl salt-sensitive rats on a high-fat diet develop hypertension and enhanced constriction to angiotensin II without changing endothelial-dependent vasorelaxation. Federation of American Societies for Experimental Biology","DOI":"10.1096\/fasebj.24.1_supplement.1025.9"},{"issue":"6","key":"1949_CR31","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/10641960701578360","volume":"29","author":"RG Morrison","year":"2007","unstructured":"Morrison RG, Mills C, Moran AL, Walton CE, Sadek MH, Mangiarua EI, Wehner PS, McCumbee WD (2007) A moderately high fat diet promotes saltsensitive hypertension in obese zucker rats by impairing nitric oxide production. Clin Exp Hypertens 29(6):369\u2013381","journal-title":"Clin Exp Hypertens"},{"issue":"2","key":"1949_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1254\/jphs.12169FP","volume":"121","author":"S Kosaka","year":"2013","unstructured":"Kosaka S, Pelisch N, Rahman M, Nakano D, Hitomi H, Kobori H, Fukuoka N, Kobara H, Mori H, Masaki T (2013) Effects of angiotensin II AT1\u2013 receptor blockade on high fat diet\u2013induced vascular oxidative stress and endothelial dysfunction in dahl salt-sensitive rats. J Pharmacol Sci 121(2):95\u2013102","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"1949_CR33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1042\/CS20030227","volume":"106","author":"T Wei-Chuan","year":"2004","unstructured":"Wei-Chuan T, Yi-Heng L, Chih-Chan L, Ting-Hsing C, Jyh-Hong C (2004) Effects of oxidative stress on endothelial function after a high-fat meal. Clin Sci 106(3):315\u2013319","journal-title":"Clin Sci"},{"issue":"1_supplement","key":"1949_CR34","first-page":"1025.9","volume":"31","author":"R Fernandes","year":"2017","unstructured":"Fernandes R, Bonilla PAP, Garver H, Galligan JJ, Fink GD, Xu H (2017) High fat diet increases salt sensitivity and promotes metabolic disorder independent hypertension in dahl salt sensitive rats. FASEB J 31(1_supplement):1025.9","journal-title":"FASEB J"},{"issue":"2","key":"1949_CR35","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1161\/HYPERTENSIONAHA.112.191551","volume":"60","author":"AM Beyer","year":"2012","unstructured":"Beyer AM, Raffai G, Weinberg B, Fredrich K, Lombard JH (2012) Dahl salt-sensitive rats are protected against vascular defects related to diet-induced obesity. Hypertension 60(2):404\u2013410","journal-title":"Hypertension"},{"issue":"11","key":"1949_CR36","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1071\/RD16265","volume":"29","author":"DP Sundrani","year":"2017","unstructured":"Sundrani DP, Roy SS, Jadhav AT, Joshi SR (2017) Sex-specific differences and developmental programming for diseases in later life. Reprod Fertil Dev 29(11):2085\u20132099","journal-title":"Reprod Fertil Dev"},{"issue":"12","key":"1949_CR37","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.3390\/ijms20122949","volume":"20","author":"C Coco","year":"2019","unstructured":"Coco C, Sgarra L, Potenza MA, Nacci C, Pasculli B, Barbano R, Parrella P, Montagnani M (2019) Can epigenetics of endothelial dysfunction represent the key to precision medicine in type 2 diabetes mellitus? Int J Mol Sci 20(12):2949","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1949_CR38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13148-015-0090-4","volume":"7","author":"F Prattichizzo","year":"2015","unstructured":"Prattichizzo F, Giuliani A, Ceka A, Rippo MR, Bonfigli AR, Testa R, Procopio AD, Olivieri F (2015) Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes. Clin Epigenetics 7(1):56","journal-title":"Clin Epigenetics"},{"issue":"17","key":"1949_CR39","doi-asserted-by":"publisher","first-page":"18091","DOI":"10.1074\/jbc.M311786200","volume":"279","author":"F Miao","year":"2004","unstructured":"Miao F, Gonzalo IG, Lanting L, Natarajan R (2004) In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 279(17):18091\u201318097","journal-title":"J Biol Chem"},{"issue":"3","key":"1949_CR40","first-page":"H319","volume":"307","author":"N Zhu","year":"2014","unstructured":"Zhu N, Liu B, Luo W, Zhang Y, Li H, Li S, Zhou Y (2014) Vasoconstrictor role of cyclooxygenase-1-mediated prostacyclin synthesis in non-insulin dependent diabetic mice induced by high-fat diet and streptozotocin. Am J Phys Heart Circ Phys 307(3):H319\u2013H327","journal-title":"Am J Phys Heart Circ Phys"},{"issue":"1","key":"1949_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/1440-1681.12501","volume":"43","author":"SS Li","year":"2016","unstructured":"Li SS, Liu B, Luo WH, Zhang YZ, Li H, Huang DY, Zhou YB (2016) Role of cyclooxygenase-1 and-2 in endothelium-dependent contraction of atherosclerotic mouse abdominal aortas. Clin Exp Pharmacol Physiol 43(1):67\u201374","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"1949_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1161\/01.HYP.0000103868.45064.81","volume":"43","author":"C Cardillo","year":"2004","unstructured":"Cardillo C, Campia U, Iantorno M, Panza JA (2004) Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients. Hypertension 43(1):36\u201340","journal-title":"Hypertension"},{"key":"1949_CR43","doi-asserted-by":"publisher","first-page":"841097","DOI":"10.1155\/2015\/841097","volume":"2015","author":"H Harizi","year":"2015","unstructured":"Harizi H (2015) Epigenetic regulations of inflammatory cyclooxygenase-derived prostanoids: molecular basis and pathophysiological consequences. Mediat Inflamm 2015:841097","journal-title":"Mediat Inflamm"},{"issue":"3","key":"1949_CR44","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/j.1476-5381.2010.01148.x","volume":"164","author":"CJ Garland","year":"2011","unstructured":"Garland CJ, Hiley CR, Dora KA (2011) EDHF: spreading the influence of the endothelium. Br J Pharmacol 164(3):839\u2013852","journal-title":"Br J Pharmacol"},{"issue":"4","key":"1949_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1042\/CS20090096","volume":"117","author":"M Feletou","year":"2009","unstructured":"Feletou M, Vanhoutte PM (2009) EDHF: an update. Clin Sci (Lond) 117(4):139\u2013155","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"1949_CR46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1748-1716.2010.02217.x","volume":"203","author":"RL Baylie","year":"2011","unstructured":"Baylie RL, Brayden JE (2011) TRPV channels and vascular function. Acta Physiol 203(1):99\u2013116","journal-title":"Acta Physiol"},{"key":"1949_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.freeradbiomed.2016.09.021","volume":"101","author":"DJ DelloStritto","year":"2016","unstructured":"DelloStritto DJ, Sinharoy P, Connell PJ, Fahmy JN, Cappelli HC, Thodeti CK, Geldenhuys WJ, Damron DS, Bratz IN (2016) 4-Hydroxynonenal dependent alteration of TRPV1-mediated coronary microvascular signaling. Free Radic Biol Med 101:10\u201319","journal-title":"Free Radic Biol Med"},{"issue":"15","key":"1949_CR48","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1007\/s00018-015-1958-3","volume":"72","author":"M Vinken","year":"2015","unstructured":"Vinken M (2015) Introduction: connexins, pannexins and their channels as gatekeepers of organ physiology. Cell Mol Life Sci 72(15):2775\u20132778","journal-title":"Cell Mol Life Sci"},{"key":"1949_CR49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1365-2362.2008.01926.x","volume":"38","author":"A Pfenniger","year":"2008","unstructured":"Pfenniger A, Derouette JP, Verma V, Roth I, Foglia B, Coombs W, Sorgen P, Taffet S, Kwak BR, Delmar M (2008) The gap junction protein Cx37 interacts with eNOS in endothelial cells. Eur J Clin Investig 38:24\u201324","journal-title":"Eur J Clin Investig"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-020-01949-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-020-01949-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-020-01949-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T23:11:08Z","timestamp":1627945868000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-020-01949-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["1949"],"URL":"https:\/\/doi.org\/10.1007\/s00109-020-01949-0","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]},"assertion":[{"value":"6 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The animal experiment was approved by the responsible regulatory authority (Landesuntersuchungsamt Rheinland-Pfalz; 23\u00a0177\u201307\/G 16\u20131-038) and was conducted in accordance with the German animal protection law and the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals. No human participants involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.PETN used in this study was provided by Actavis Deutschland (now PUREN Pharma GmbH & Co. KG, Munich, Germany).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}